Home Offices/Resources Fall 2021 Campus Update

Fall 2021 Campus Update

Click here to view the full Saints Rebound guide to MU's 2021-22 opening.

The COVID-19 vaccine has been mandated by the University. All students, staff, and faculty members must be fully vaccinated by September 17th.

Students: please submit proof of vaccine via the SHC patient portal. Click here to view the SHC Patient Portal Instruction Sheet. If you are in need of an exemption from the vaccine, please let Student Health Services know by completing a COVID vaccination exemption form.
Click here to complete the exemption form

Faculty and Staff: please report your vaccination record (and test results) using Workday's Safety Incident module. You may upload a copy of your vaccination record and test results for personal safekeeping.  For a quick demo, visit our HR site - COVID-19 Resources - "Demo: Reporting COVID-19 Vaccinations/Results in Workday." If you are in need of an exemption from the vaccine, please print and fill out this form, then return to Human Resources (HR) by email at or in person.

COVID-19 Cases among Marymount Students, Staff, and Faculty

Our case count tracks cases diagnosed beginning at the start of spring semester, 1/19/2021, as well as those currently active.
From 8/23/2021 until today 10/21/2021, there have been:
Positive cases of COVID-19 among community members.

Currently, there are:
Active case(s).
Contact tracing begins immediately after a positive case has been presumed (which can occur due to a positive test or display of certain symptoms). If at any time you have been in close contact with a positive case, you will be notified by Student Health Services and given instructions for quarantine.

Regarding Marymount's Fall 2020 numbers, our final case count was 95 for the semester.

Johnson & Johnson Vaccine Update

In light of the April 13 announcement about the pausing of the Johnson & Johnson (J&J) COVID-19 vaccine, we wanted to share some context and information to help give some perspective on these events.

Six individuals have developed a rare but severe blood clot called cerebral venous sinus thrombosis with low platelets, which is thought to be associated with the J&J vaccine. Of those six, there has been one death. Over 6.8 million doses of the J&J vaccine have been administered, making the likelihood of this occurrence happening significantly lower than .01%.

The six individuals have been women between the ages of 18-48 years, and the symptoms have occurred 6-13 days after the vaccine was administered. Anyone who has received the J&J vaccine within the past three weeks and develops a severe headache, abdominal pain, leg pain, or shortness of breath should contact their health care provider.

The CDC and FDA are reviewing these cases to assess their potential significance. While the investigation occurs, it has been recommended that there be a pause in the administering of the J&J vaccine. All vaccine adverse events are reported to the Vaccine Adverse Event Reporting System.

The CDC and FDA have provided additional information on the FDA’s YouTube channel. Please let us know if we can answer any questions or concerns - Student Health Services is here to help and support.